Abstract
Investment in animal genetic improvement in Australia involves a diverse range of stakeholders and tackles complexity in a range of markets and production environments. While an excellent range of tools and knowledge for genetic improvement has been developed, industry-wide rates of genetic progress lag well below what is possible. This constitutes a considerable opportunity cost to the investors and to the wider community. It is proposed that this is partly a problem of coordination of effort across many diverse interests, and that this problem will be exacerbated by increasing availability, but complexity of use of genotypic information. Some approaches aimed at improving coordination and hence efficiency of investment are suggested, with consideration of the role of research and development corporations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
